Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Cancer. 2018 Apr 6;124(16):3293–3306. doi: 10.1002/cncr.31367

Table 2.

Summary of alternative payment and care delivery models in cancer care

First Author Intervention | Payer type Study Design | Setting | Cancer studied Peer-review Patients in intervention | control Brief Description Outcomes Measured Results Impact on Value
Bundled Payments
Bandell14 BCBS of Florida Radical Prostatectomy Bundle | Private NA | Community | Prostate No NA BCBS partnered with Mobile Surgery International to develop prostatectomy bundle for early stage prostate cancer. NA NA NA
Butcher15 CTCA Bundle | Private NA | Community | prostate, breast, lung and colorectal No NA CTCA developed a bundle for the diagnosis and care planning of 4 cancer types. Episodes included medical, surgical and radiation oncologist consults, imaging and pathology services, and other consult services. NA NA NA
Castelluci16 BCBS of CA Breast Cancer Bundle | Private NA | Community | Breast No NA BCBS partnered with Valley Radiotherapy Associated Medical Group to develop a radiation bundle for early stage breast cancer. NA NA NA
Feeley17 MD Anderson Head and Neck Bundle | Private NA | NCI designated cancer center | Head and neck No NA UHC partnered with MD Anderson to develop a bundle covering comprehensive services to manage head and neck cancer. Episode length of 12 months. NA NA NA
Loy18 EBRT Bundle | Private Pre-post with concurrent control | Community | Breast, Lung, Skin, Prostate cancer, and Bone metastases Yes 515 | 433 Humana partnered with 21st Century Oncology practice to form a bundle for EBRT. Episode length of 90 days. Guideline concordance, under- and over- treatment. No change in guideline concordant care for breast, lung, and skin cancers.
Improvements in guideline care for bone metastases and prostate cancer.
Under-treatment declined from 4% to 0%. Over-treatment was unchanged.
Neutral
Newcomer19 UHC Bundle Pilot | Private Pre-post with concurrent control | Community | Breast, lung, colon Yes 810 | NA UHC partnered with 5 medical oncology groups. Episodes included hospital care, hospice, case management, and eliminated % based chemotherapy drug incentive. Episodes length of 4–12 months. Hospitalizations, therapeutic radiology use, chemotherapy drug cost, net savings. Decreased hospitalization and therapeutic radiology use.
Increase in chemotherapy drug costs.
Net savings of $33.36 million.
Increased
Accountable Care Organizations
Butcher20 Aetna Cancer-Specific ACO | Private Pre-post for costs, Cohort study for utilization | Community | Breast, Lung, Colon No 184 | NA Aetna partnered with Texas Oncology to form ACO pilot. ER visits, hospitalizations, LOS, costs. 40% fewer emergency room visits. 16.5% fewer hospitalizations. 36% fewer inpatient days. 10% lower 1-year costs, 12% lower 2-year costs. Increased
Colla21 PGPD Project | Medicare Pre-post with concurrent control | Community | All Yes 104,766 | 727,969 Medicare claims analysis of cancer outcomes after PGPD. Hospitalizations, costs. PGPD enrollment was associated with a $721 (3.9%) reduction in annual Medicare spend per patient, which was driven exclusively by decreased inpatient stays. Increased
Herrel22 MSSP ACO Analysis | Medicare Pre-post with concurrent control | Mixed settings | Colorectal, bladder, esophageal, kidney, liver, ovarian, pancreatic, lung, or prostate cancer Yes 19,439 | 365,080 Medicare claims analysis of surgical cancer outcomes after MSSP enrollment. Mortality, readmissions, complications, LOS. ACO enrollment had no effect on 30-day mortality, readmissions, complications, or LOS. Neutral
Mehr23 BCBS Cancer- Specific ACOs | Private NA | NCI designated cancer center, Community | All Yes NA BCBS partnered with Moffit Cancer Center, Baptist Health South Florida and Advanced Medical Specialties, to form a cancer ACO. NA NA NA
Patient Centered Medical Homes
Bosserman24 Wilshire Oncology Pilot| Private NA | Community | All Yes NA Wilshire Oncology partnered with CA Anthem Blue Cross WellPoint to form an oncology medical home pilot. NA NA NA
Butcher25 COA Initiative | Mixed NA | Community | All No NA COA approached CMMI and private payers about a medical home demonstration project. NA NA NA
Goyal27 North Carolina Medicaid PCMH | Medicaid Concurrent comparator | Mixed settings | Breast Yes 308 | 262 Medicaid claims analyses of breast cancer patients enrolled in the Community Care of North Carolina PCMH. Outpatient or ER visits for chemo-related adverse event. PMCH enrollment was not associated with differences in outpatient or ER visits for chemo-related adverse events. Decreased
Kohler26 Concurrent comparator | Mixed settings | Breast Yes 3,857 person-months | 5,550 person-months Medicaid claims analyses of breast cancer patients enrolled in the Community Care of North Carolina PCMH. Outpatient service use, ER visits, hospitalizations, costs. PCMH enrollment was associated with higher monthly outpatient service utilization, no effect on ER visits or hospitalizations, and a $429 per month increase in expenditures for the first 15 months. This effect was not significant at 24–36 months.
Kuntz28 Michigan Oncology Medical Home | Private Pre-Post | Community | All Yes 85 | 485 4 oncology practices partnered with Priority Health to develop a model that reimbursed for chemo and treatment planning and advanced care planning consultation with a shared savings opportunity. ER visits, hospitalizations, costs. Reduced ER visits by 47% and hospitalizations by 68%. Estimated savings per patient was $550. Increased
Reinke29 CareFirst | Private Pre-post with concurrent control | NA | NA No 8 pilot practices | 7 control practices A Maryland/Washington BCBS plan that created a voluntary medical home model based on its pathway program. Office visits, # cycles per patient, % receiving chemo, % receiving all-generic chemotherapy. No effect on office visits, average number of cycles given per patient, proportion of patients receiving chemotherapy, and proportion of patients receiving all-generic chemotherapy. Neutral
Shah30 National PCMH | NA Concurrent comparator | Mixed settings | All No* NA | NA Survey analysis of PCMH access and outcomes for cancer survivors. ER visits, prescribing behavior, outpatient visits, hospitalizations, costs. Reduced ER visits and prescription medications for cancer survivors with access to PCMH. No effect on outpatient visits, hospitalizations, or total costs. Neutral
Sprandio12 CMOH | Private Pre-post | Community | All Yes NA|NA CMOH, a nine-Oncologist physician practice, formed the first oncology medical home. ER visits, hospitalizations, LOS, costs. Reduced ER visits by 68%, hospitalizations by 51%, and LOS by 21%. Approximate aggregate savings of $1 million per physician per year to insurers. Increased
Tirodkar31 Patient-centered oncology practice standards pilot | NA NA | Mixed | NA Yes NA Pilot of incorporating patient-centered oncology practice standards at 5 oncology practices. Standards included improved communication, care coordination, and performance measurement. NA NA NA
Waters32 COME HOME | Medicare Pre-Post | Community | Breast, Lung, or Colon Yes 16,353 | NA Received a grant from CMMI to replicate and scale a patient centered cost-reduction program across 7 oncology practices. ER visits, hospitalizations, patient satisfaction. Participating sites reduced ER visits by 23% and hospitalizations by 28%. Patient satisfaction rates remained >90%. Increased
Other Alternative Payment or Care Delivery Interventions
Kwon33 Glioma IPU | NA NA | Community | Glioma, metastatic cancer to the brain, meningioma No* NA Virtual IPU including neurosurgery, neuro oncology, radiation oncology, neuroradiology, and neuropathology. NA NA NA
Sharma34 The Diabetes Oncology Program | NA Pre-post | Community | All No× 98 | 383 Integrated care model including oncologist, endocrinologist, primary care physician, nursing staff, and diabetes educator. ER visits, hospitalizations. Reduced aggregate ER visits, observation stays, and hospitalizations by 3.4% in cancer patients with diabetes. Increased
Timmins35 Gynecologic Oncology capitated model | Private NA | Community | Gynecologic cancers No* NA Private practice group partnered with health plan to create a capitated annual payment per patient (excluding drug costs). NA NA NA

Abbreviations: BCBS = Blue Cross Blue Shield; NA = Not available; CTCA = Cancer Treatment Centers of America; CA = California; NCI = National Cancer Institute; UHC = United Healthcare; EBRT = External beam radiation; ER = Emergency room; LOS = length of stay; PGPD = Physician Group Practice Demonstration; MSSP = Medicare Shared Savings Program; COA = Community Oncology Alliance; CMMI = Center for Medicare & Medicaid Innovation; CMOH = Consultants in Medical Oncology and Hematology; COME HOME = Community Oncology Medical Home; IPU = Integrated Practice Unit.

*

Abstract Only

×

Graduate School Dissertation